Samsung heir Jae-yong faces another probe over anesthesia drug use

Jae-yong, the imprisoned de facto leader of Samsung Group, is under investigation over an allegation that he took anesthesia drug propofol shots illegally, police said on Thursday

Lee Jae-yong, Samsung, jail
Jae-yong
IANS Seoul
2 min read Last Updated : Mar 11 2021 | 10:22 AM IST

Jae-yong, the imprisoned de facto leader of Samsung Group, is under investigation over an allegation that he took anesthesia drug propofol shots illegally, police said on Thursday.

Propofol is a highly regulated drug in South Korea that the country's Ministry of Food and Drug Safety issued standards to prevent its misuse and abuse.

The ministry issued a notice last September to set standards for the use of narcotic drugs propofol and zolpidem, saying propofol is a "psychotropic drug used to induce and maintain the general anesthetic state."

The Gyeonggi Nambu Police Agency said they were looking into the accusation made against Lee, vice chairman of Samsung Electronics, that he illegally used the anesthesia drug at a plastic surgery clinic in Seoul last year, but refused to provide further details on the ongoing case, reports Yonhap news agency.

The police are said to have visited Lee, who is imprisoned in the Seoul Detention Center in Uiwang, south of the capital, last month to take a hair sample from him for drug testing.

Lee is currently serving a two-and-a-half-year prison term for bribing impeached former President Park Geun-hye and her longtime friend Choi Soon-sil to win government support for a smooth father-to-son transfer of managerial power at Samsung.

Samsung said that Lee only took propofol shots for medical purposes and that the police have not corroborated the allegation against him, reports Yonhap news agency.

Early last year, a similar accusation was filed against Lee with the Anti-Corruption and Civil Rights Commission that he regularly used propofol at another plastic surgery clinic in Seoul.

The case has been referred to the Supreme Prosecutors Office.

Lee also denied the allegation at that time and requested the case to be reviewed by an independent committee consisting of outside experts to see whether the prosecution's investigation is legitimate.

--IANS

wh/na

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Samsung

First Published: Mar 11 2021 | 10:15 AM IST

Next Story